Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Sales: 2012-2024

Historic Return on Sales for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to 0.20%.

  • Amphastar Pharmaceuticals' Return on Sales fell 8.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.20% for FY2024, which is 1.00% down from last year.
  • Amphastar Pharmaceuticals' Return on Sales amounted to 0.20% in FY2024, which was down 4.12% from 0.21% recorded in FY2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Sales registered a high of 0.21% during FY2023, and its lowest value of 0.00% during FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Return on Sales had a median value of 0.20% in 2024 and averaged 0.20%.
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Sales decreased by 19bps in 2020 and then grew by 14bps in 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Return on Sales (MRY) stood at 0.00% in 2020, then surged by 4,527bps to 0.15% in 2021, then rose by 21bps to 0.18% in 2022, then grew by 20bps to 0.21% in 2023, then decreased by 4bps to 0.20% in 2024.
  • Its last three reported values are 0.20% in FY2024, 0.21% for FY2023, and 0.18% during FY2022.